Save
PB0014 Do Antiphospholipid Antibodies Inform the Choice of Anticoagulant Agents in Patients with Atrial Fibrillation?
ISTH Academy, Faculty / Presenters, 406506
PB0011 Evaluation of the Association between Clinical Events and Apixaban/ Rivaroxaban’s Plasma exposure in Patients from the OptimAT Study
ISTH Academy, Faculty / Presenters, 406507
PB0012 Anticoagulant use and Prognosis of Non-Valvular Atrial Fibrillation Patients According to Baseline CHA2DS2-VASc Score and HAS-BLED Score
ISTH Academy, Faculty / Presenters, 406508
PB0010 Neutrophil-Activating Peptide 2 as a Novel Modulator of Fibrin Clot Properties in Patients with Atrial Fibrillation on Anticoagulation
ISTH Academy, Faculty / Presenters, 406509
PB0035 Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-Coated Aspirin in Patients with StablE Diabetes: Preliminary Findings from the APPEASED Study
ISTH Academy, Faculty / Presenters, 406510
PB0033 Validated in vivo Model to Assess Direct Oral Anticoagulant Reversal Agents
ISTH Academy, Faculty / Presenters, 406511
PB0034 Endogenous Dysregulation of Biomarkers of Thromboinflammatory Responses in End-Stage Renal Disease, and Their Amplification by Heart Failure
ISTH Academy, Faculty / Presenters, 406512
PB0030 The Association between Depressive Symptom Profiles and Hemostasis: The Biobehavioral Pathway to Cardiovascular Diseases?
ISTH Academy, Faculty / Presenters, 406513
PB0032 Interpaly of Oxidative Stress Markers with Thrombo-Inflammatory Barkers in End Stage Renal Disease
ISTH Academy, Faculty / Presenters, 406514
PB0031 Natural Antibodies to Oxidation-Specific Epitopes Characterize Hemodialysis Patients Protected from Cardiovascular Events
ISTH Academy, Faculty / Presenters, 406515
PB0029 Bridging Therapy and Risk of Major Bleeding and Thrombosis with Continuous-Flow Left Ventricular Assist Device: A Quasi-Experimental Study
ISTH Academy, Faculty / Presenters, 406516
PB0027 Assessing Genetic Risk Factors for Early-Onset Coronary Artery Disease in Iranians
ISTH Academy, Faculty / Presenters, 406517
PB0028 The Impact of Cannulation Site on Bleeding and Thrombotic Outcomes in Venovenous ECMO
ISTH Academy, Faculty / Presenters, 406518
PB0026 Low Platelet Count has a Strong Worsening Impact on Outcome in Patients with Acute Coronary Syndromes: From the START Antiplatelet Registry
ISTH Academy, Faculty / Presenters, 406519
PB0043 Hypercoagulable State and Mortality in ICU Patients during 2020–2022: A Single Centre Report
ISTH Academy, Faculty / Presenters, 406520
PB0039 Long Term Follow-Up of Cerebral Magnetic Resonance Imaging in Patients with Antiphospholipid Syndrome Assessing the Risk Factors for Recurrent Cerebral Events
ISTH Academy, Faculty / Presenters, 406521
PB0041 Prevalence of Vascular Risk Factors and I/D Angiotensin-Converting Enzyme Gene (ACE) Polymorphism in Costa Rican Elderly Patients with Cognitive Impariment
ISTH Academy, Faculty / Presenters, 406522
PB0040 Assessing Inter-Operator Variability in Gating Strategy of Whole Blood Monocyte Subsets Using Flow Cytometry in Patients with Acute Stroke Suspicion
ISTH Academy, Faculty / Presenters, 406523
PB0037 Thrombotic Cerebrovascular Outcomes in Patients with Fibromuscular Dysplasia Treated with Antiplatelet Agents or Anticoagulants: A Single-Center Experience
ISTH Academy, Faculty / Presenters, 406524
PB0036 Plasma Protein Carbonyl Levels Contribute to Prothrombotic Fibrin Clot Phenotype in Acute Ischemic Stroke Patients: Associations with Clinical Outcomes
ISTH Academy, Faculty / Presenters, 406525
PB0045 SEM and 3D Reconstruction of ex-vivo Arterial Thrombi: A Pilot Study
ISTH Academy, Faculty / Presenters, 406526
PB0044 Pediatric Arterial Thrombosis: Patient Characteristics and Thrombosis Outcomes
ISTH Academy, Faculty / Presenters, 406527
PB0529 Haemostatic Properties of Chromolaena Odorata: Evaluation of in vivo and in vitro Activity
ISTH Academy, Faculty / Presenters, 406528
PB0527 Assessment of the Rats Model of Hemophilic Arthritis by Micro CT Scanning
ISTH Academy, Faculty / Presenters, 406529
PB0525 Identification of an Aberrant Cell Population in a Knock-in Murine Model with RUNX1 Variant Generated by CRISPR/Cas9
ISTH Academy, Faculty / Presenters, 406530
PB0522 Characterization of Coagulopathy in a Swine Muscle Injury Model
ISTH Academy, Faculty / Presenters, 406531
PB0523 Effect of Flow on Structural and Mechanical Properties of the Fibrin Network in Plasma Thrombi
ISTH Academy, Faculty / Presenters, 406532
PB0524 Preparation and Characterization of Nanocarriers for Transdermal Delivery of Enoxaparin
ISTH Academy, Faculty / Presenters, 406533
PB0520 Atorvastatin Treatment Inhibits the Procoagulant Properties of a 3D Culture Model of the Human Neointimal Layer
ISTH Academy, Faculty / Presenters, 406534
PB0521 Development and Characterization of Novel Nanoparticulate Carrier for Oral Delivery of Low Molecular Weight Heparin
ISTH Academy, Faculty / Presenters, 406535
PB0519 Age-Dependent Changes in Mortality and Biomarkers of Immunothrombosis in a Murine Model of Sepsis
ISTH Academy, Faculty / Presenters, 406536
PB0517 Enhancement of Experimental Venous Thrombosis in Sickle Trait Mice is Prevented by Gardos Channel Inhibition
ISTH Academy, Faculty / Presenters, 406537
PB0518 Novel Insights into Antifibrinolytic and Prothrombotic Functions of Lipoprotein(a)
ISTH Academy, Faculty / Presenters, 406538
PB0516 Andexanet Alfa Versus 4-F Prothrombin Complex Concentrate in an Apixaban Anticoagulated Porcine Polytrauma Model
ISTH Academy, Faculty / Presenters, 406539
PB0586 Protein S Deficiency is Associated with an Increased Risk of Deep Vein Thrombosis in Pregnant Women Using Oral Contraceptive
ISTH Academy, Faculty / Presenters, 406540
PB0582 Differential Neutralization of Bovine Heparins as Measured by Functional Assays and Absolute Quantification of Glycosaminoglycan Context
ISTH Academy, Faculty / Presenters, 406541
PB0584 Using Heparin-Calibrated Assays to Assess Anti-Factor Xa Activity of Factor Xa Inhibitors (FXaI): A Literature Correlation Analysis
ISTH Academy, Faculty / Presenters, 406542
PB0578 Antithrombin Deficiency Responsible for Repeated Thromboembolic Complications – Case Report
ISTH Academy, Faculty / Presenters, 406543
PB0579 Approaches to Assure Similarity of Pharmaceutical Preparations of Unfractionated Heparin
ISTH Academy, Faculty / Presenters, 406544
PB0580 Laboratory Diagnosis of Prekallikrein Deficiency: Importance of Suspicion and Laboratory Method
ISTH Academy, Faculty / Presenters, 406545
PB0576 Correlation between High Affinity Material for Antithrombin and Anticoagulant Activities of Heparin
ISTH Academy, Faculty / Presenters, 406546
PB0577 Heparin Potency Assays – Reagents can Cause Differences in Potency Assignment
ISTH Academy, Faculty / Presenters, 406547
PB0575 Novel Variants of PROS1 Gene Related to Protein S Deficiency
ISTH Academy, Faculty / Presenters, 406548
PB0570 A Comparison of Heparins from Porcine and Bovine Origins in Various Laboratory Assays
ISTH Academy, Faculty / Presenters, 406549
PB0571 Analysis of the Risk Factors on the Development of Thromboembolic Complications
ISTH Academy, Faculty / Presenters, 406550
PB0572 Potency-Adjusted Bovine Heparin Exhibits Similar Anticoagulant Effects as Porcine Heparin in Whole Blood Clotting Studies
ISTH Academy, Faculty / Presenters, 406551
PB0573 Routine Haemostasis Profile in Sickle Cell Disease Patients in Steady State: A Retrospective, Descriptive Study
ISTH Academy, Faculty / Presenters, 406552
PB0574 Severe Bleeding in an Acquired Factor XIII Deficiency in an Otherwise Healthy Patient
ISTH Academy, Faculty / Presenters, 406553
PB0569 Elevated International Normalized Ratio in Hospitalized Patients Treated with Direct Oral Anticoagulants
ISTH Academy, Faculty / Presenters, 406554
PB0562 Effects of High-Fat and High-Carbohydrate Meals on Coagulation and Anticoagulation Factors and Lipid Profile
ISTH Academy, Faculty / Presenters, 406555
PB0563 Evaluation of the Rapid and Easy-to-Use Point-of-Care qLabs FIB® System to Quantify Functional Fibrinogen Levels in Patients Undergoing Plasma Exchange Therapy
ISTH Academy, Faculty / Presenters, 406556
PB0564 Evaluation of the Significance of Mixing Study in Lupus Anticoagulant Testing Using A New CMC Algorithm
ISTH Academy, Faculty / Presenters, 406557
PB0565 Long-Term ex-situ Normothermic Machine Perfusion of Human Livers Provides a Platform to Study (Patho)Physiology and Production of Hemostatic Proteins
ISTH Academy, Faculty / Presenters, 406558
PB0566 Prediction and Validation of the Effects of Targeting either Coagulation FXI Activation or Activity on Thrombin Generation
ISTH Academy, Faculty / Presenters, 406559
PB0568 X-Ray Structures of Thrombin Bound to Heterobifunctional Aptamer-Drug Conjugates Reveal the Mechanistic Basis for a Novel Tethered Inhibition Strategy
ISTH Academy, Faculty / Presenters, 406560
PB0554 A Phase 1/2 Study to Determine the Dose-Response Relationship by Assessment of Thrombin Generation After 4-Factor PCC in Healthy Subjects under Vitamin K Antagonist Anticoagulation
ISTH Academy, Faculty / Presenters, 406561
PB0555 Efficacy and Safety of 4-Factor Prothrombin Complex Concentrate for Management for Direct Xa Inhibitor-Induced Major Bleeding
ISTH Academy, Faculty / Presenters, 406562
PB0556 Evaluation of the ACL TOP 970 CL Analyser for Clotting, Chromogenic and Immunoturbidimetric Assays for Thrombophilia
ISTH Academy, Faculty / Presenters, 406563
PB0557 Fermentation of Sweet Corn Produced a Very High Concentration of Vitamin K
ISTH Academy, Faculty / Presenters, 406564
PB0558 Lack of Interaction of Milvexian, an Investigational Oral FXIa Inhibitor with Aspirin and Ticagrelor on Platelet Aggregation, Thrombin Generation and Thromboelastography in vitro
ISTH Academy, Faculty / Presenters, 406565
PB0559 Novel Variants of PROS1 Gene Related to Protein S Deficiency
ISTH Academy, Faculty / Presenters, 406566
PB0560 Step-by-Step Production and Biological Evaluation of Novel Aryl Piperazine-based FXa Inhibitors
ISTH Academy, Faculty / Presenters, 406567
PB0551 A Comparison of USP Potency Adjusted and Mass Adjusted Heparins of Bovine, Ovine, and Porcine Origin in Various Assays
ISTH Academy, Faculty / Presenters, 406568
PB0552 Performance Evaluation of the ACTICHROME Heparin Anti-Xa Assay for the Quantitative Determination of Unfractionated Heparin and Low-Molecular-Weight Heparin Plasma Concentrations
ISTH Academy, Faculty / Presenters, 406569
PB0553 Role of International Society of Thrombosis and Hemostasis-Bleeding Assessment Tool, RICOF, ROTEM, and APTT-Clot wave form Analysis (CWA) in Evaluation of Patients with Bleeding of Unknown Cause (BUC)
ISTH Academy, Faculty / Presenters, 406570
PB0548 Efficacy of Direct Oral Anticoagulants in Liver Cirrhosis: An in-vitro Study
ISTH Academy, Faculty / Presenters, 406571
PB0549 Healthcare Resource Use Among US Veterans Treated with Andexanet Alfa or 4-Factor Prothrombin Complex Concentrate for Factor Xa Inhibitor-Related Major Bleeding
ISTH Academy, Faculty / Presenters, 406572
PB0550 Novel Variants of PROS1 Gene Related to Protein S Deficiency
ISTH Academy, Faculty / Presenters, 406573
PB0546 Effect of Atorvastatin on IL-6 and F1+2 in High Risk Thrombosis Patients with Cancer Undergoing Chemotherapy
ISTH Academy, Faculty / Presenters, 406574
PB0547 Poly(Sodium Styrenesulfonate)-based Copolymers with Anticoagulant Activity: Preliminary Efficacy and Safety Studies
ISTH Academy, Faculty / Presenters, 406575
PB0538 A Monoclonal Antibody against Human Factor V Impairs its Activation and Procoagulant Function
ISTH Academy, Faculty / Presenters, 406576
PB0539 Detection of TFPI Citrullination in Blood after Neutrophil Activation by PMA
ISTH Academy, Faculty / Presenters, 406577
PB0541 Expression of Recombinant Human Factor VII Activating Protease (FSAP) and Exploration of its 3D Structure Using AlphaFold
ISTH Academy, Faculty / Presenters, 406578
PB0542 Investigating Thrombin-Loaded Fibrin in Whole Blood Clot Microfluidic Assay via Fluorogenic Peptide
ISTH Academy, Faculty / Presenters, 406579
PB0543 Like Heparin, Polyphosphate Promotes the Formation of a Ternary Complex with Thrombin and Fibrin
ISTH Academy, Faculty / Presenters, 406580
PB0544 Management of Inherited Antithrombin Deficiency in Pregnancy and Puerperium: Single Center Experience
ISTH Academy, Faculty / Presenters, 406581
PB0545 The Effect of a History of Preeclampsia on Hemostatic Balance in the Non-Pregnant State
ISTH Academy, Faculty / Presenters, 406582
PB0535 Development of Function-Blocking Antibodies to Plasma Prekallikrein for the Study of the Interplay between Coagulation and Inflammation
ISTH Academy, Faculty / Presenters, 406583
PB0536 Oral Factor XIIa Inhibitor KV998086 Protects Against FeCl3 Induced Thrombosis in Mice
ISTH Academy, Faculty / Presenters, 406584
PB0537 Tissue Factor Pathway Inhibitor and Tissue Factor Pathway Inhibitorrs7586970 Variant in Myocardial Infarction with Type 2 Diabetes Mellitus
ISTH Academy, Faculty / Presenters, 406585
PB0533 New Low Molecular Weight Heparin Antidote Based on an Antithrombin Mutant
ISTH Academy, Faculty / Presenters, 406586
PB0534 Rapid Measurement of DOAC Concentration and Platelet Function Using Whole Blood in a Disposable Microfluidic Device
ISTH Academy, Faculty / Presenters, 406587
PB0531 Mechanical Behavior of Clots: Molecular Mechanism of Forced Unfolding of Crosslinked Fibrin Protofibrils
ISTH Academy, Faculty / Presenters, 406588
PB0532 The Factor XIa Antibody Osocimab Combined with Enoxaparin Strongly Inhibits Clotting in Extracorporeal Circuits in vitro
ISTH Academy, Faculty / Presenters, 406589
PB0530 Sex-Specific Differences in Procoagulant Profiles
ISTH Academy, Faculty / Presenters, 406590
PB0598 Blood Anticoagulant Impacts Endogenous Thrombin Generation in a Peripartum Population
ISTH Academy, Faculty / Presenters, 406591
PB0596 Characterization of Anti-Polyphosphate Monoclonal Antibodies
ISTH Academy, Faculty / Presenters, 406592
PB0597 Specificity of Contact Pathway Inhibitors with Regard to Other Coagulation and Fibrinolysis Proteases
ISTH Academy, Faculty / Presenters, 406593
PB0593 Extending the Circulatory Half-Life of an Engineered Kallikrein-Specific Inhibitor
ISTH Academy, Faculty / Presenters, 406594
PB0594 Factor XI Localization in Human Deep Venous Thrombus and Function of Activated Factor XI on Mural Thrombus Formation Under Low-Shear Condition
ISTH Academy, Faculty / Presenters, 406595
PB0591 Alphafold AI based Applications Explored as Tools for Predicting Contact Proteins PK, FXI and HK Structure and Evolutionary Relationships
ISTH Academy, Faculty / Presenters, 406596
PB0595 The Profile of Contact Activation System Proteins in Human Abdominal Aortic Aneurysm Plasma-and Tissue Samples
ISTH Academy, Faculty / Presenters, 406597
PB0592 Evaluation of the Role of Skeletal Muscle Myosin as a Cofactor for Factor XI Activation of Factor XII
ISTH Academy, Faculty / Presenters, 406598
PB0588 Epitope Mapping of the α-FXIIa Allosteric Inhibitor Monoclonal Antibody 5C12
ISTH Academy, Faculty / Presenters, 406599
PB0589 Human Transthyretin (hTTR) Amyloid Fibrils Induce Plasma Clotting by Activating the Intrinsic Pathway of Blood Coagulation: Implications in the Pathogenesis of hTTR Intracardiac Thrombosis
ISTH Academy, Faculty / Presenters, 406600
PB0590 The Control of Protein Binding on Bio-Interface by a Novel Coating to Prevent Contact Activation on Biomaterials
ISTH Academy, Faculty / Presenters, 406601
PB0587 Identifying Variants of AAT M358R with Increased Selectivity for Plasma Kallikrein
ISTH Academy, Faculty / Presenters, 406602
PB1048 Implementation of Electronic Medical Records in a Resource-Limited Haematology Department in North-West Nigeria
ISTH Academy, Faculty / Presenters, 406603
PB1047 A Patient with Severe, Refractory ITP and GI Bleeding is kept Hemodynamically Stable over Days with a Combination Therapy of Tranexamic Acid, Recombinant FVIIa, F XIII and Red Blood Cell Concentrates
ISTH Academy, Faculty / Presenters, 406604
PB1046 Early Goal-Directed Hemostatic Therapy (EGDHT) for Severe Acute Bleeding Management in the Intensive Care Unit
ISTH Academy, Faculty / Presenters, 406605

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings